Terms: = Liver cancer AND ATP2B3, PMCA3, 492, ENSG00000067842 AND Clinical Outcome
3 results:
1. Thymidylate synthase gene polymorphisms as important contributors affecting hepatocellular carcinoma prognosis.
Wang X; Sun X; Du X; Zhou F; Yang F; Xing J; Dong G; Guo X
Clin Res Hepatol Gastroenterol; 2017 Jun; 41(3):319-326. PubMed ID: 28043790
[TBL] [Abstract] [Full Text] [Related]
2. SNP rs2057482 in HIF1A gene predicts clinical outcome of aggressive hepatocellular carcinoma patients after surgery.
Guo X; Li D; Chen Y; An J; Wang K; Xu Z; Chen Z; Xing J
Sci Rep; 2015 Jun; 5():11846. PubMed ID: 26115041
[TBL] [Abstract] [Full Text] [Related]
3. Prognostic role of pre-treatment serum AFP-L3% in hepatocellular carcinoma: systematic review and meta-analysis.
Cheng J; Wang W; Zhang Y; Liu X; Li M; Wu Z; Liu Z; Lv Y; Wang B
PLoS One; 2014; 9(1):e87011. PubMed ID: 24498011
[TBL] [Abstract] [Full Text] [Related]
